The trans-subclavian retrograde approach for transcatheter aortic valve replacement: Single-center experience

Journal of Thoracic and Cardiovascular Surgery

Volumn 140, Issue 4, 2010, Pages

  Bruschi, Giuseppe ^a   Fratto, Pasquale ^a   De Marco, Federico ^a   Oreglia, Jacopo ^a   Colombo, Paola ^a   Botta, Luca ^a   Cannata, Aldo ^a   Moreo, Antonella ^a   De Chiara, Benedetta ^a   Lullo, Francesca ^a   Paino, Roberto ^a   Martinelli, Luigi ^a   Klugmann, Silvio ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANESTHESIST; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; AXILLARY ARTERY; CONTROLLED STUDY; FEMALE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PACEMAKER; PNEUMONIA; PRIORITY JOURNAL; RISK FACTOR; SUBCLAVIAN ARTERY; SURGEON; AORTA VALVE; AORTIC VALVE STENOSIS; CONVALESCENCE; FEASIBILITY STUDY; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HEMODYNAMICS; INTERVENTIONAL RADIOLOGY; ITALY; PATHOPHYSIOLOGY; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX; TIME; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; AXILLARY ARTERY; CARDIAC CATHETERIZATION; FEASIBILITY STUDIES; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; ITALY; MALE; RADIOGRAPHY, INTERVENTIONAL; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX; SUBCLAVIAN ARTERY; TIME FACTORS; TREATMENT OUTCOME;

EID: 77956821936     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2010.01.027     Document Type: Article

References (22)

1. M. Lindroos, M. Kupari, J. Heikkila, and R. Tilvis Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample J Am Coll Cardiol 2 1993 1220 1225
2. R.O. Bonow, B. Carabello, and K. Chatterjee ACC/AHA 2006 guidelines for the management of valvular heart disease J Am Coll Cardiol 48 2006 e1 e148
3. E. Charlson, A.T. Legedza, and M.B. Hamel Decision-making and outcomes in severe symptomatic aortic stenosis J Heart Valve Dis 15 2006 312 321
4. A. Cribier, H. Eltchaninoff, and A. Bash Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description Circulation 106 2002 3006 3008
5. J.G. Webb, M. Chandavimol, and C. Thompson Percutaneous aortic valve implantation retrograde from the femoral artery Circulation 113 2006 842 850
6. J. Ye, A. Cheung, and S.V. Lichtenstein Transapical aortic valve implantation in humans J Thorac Cardiovasc Surg 131 2006 1194 1196
7. E. Grube, L. Buellesfeld, and R. Mueller Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving System Circ Cardiovasc Intervent 1 2008 167 175
8. J.G. Webb, L. Altwegg, and R.H. Boone Transcatheter aortic valve implantation - impact on clinical and valve-related outcomes Circulation 119 2009 3009 3016
9. E. Grube, J.C. Laborde, and U. Gerckens Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: The Siegburg First-in-Man Study Circulation 114 2006 1616 1624
10. M.B. Leon, S. Kodali, and M. Williams Transcatheter aortic valve replacement in patients with critical aortic stenosis: rationale, device descriptions, early clinical experiences, and perspectives Semin Thorac Cardiovasc Surg 18 2006 165 174
11. B. Marcheix, Y. Lamarche, and C. Berry Surgical aspects of endovascular retrograde implantation of the aortic CoreValve bioprosthesis in high-risk older patients with severe symptomatic aortic stenosis J Thorac Cardiovasc Surg 134 2007 1150 1156
12. N. Piazza, E. Grube, and U. Gerckens Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve ReValving System: results from the multicentre, expanded evaluation registry 1-year following CE mark approval EuroIntervention 4 2008 242 249
13. PC Block: The Next Generation of Transcatheter Aortic Valve Devices. Cardiac Interventions Today. 2009: September 79-82. Available at: http://www.bmctoday.net/citoday/2009/09. Accessed September 20, 2009.
14. A. Cribier, H. Eltchaninoff, and C. Tron Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis J Am Coll Cardiol 43 2004 698 703
15. T. Walther, P. Simon, and T. Dewey Transapical minimally invasive aortic valve implantation multicenter experience Circulation 116 11 Suppl 2007 I240 I245
16. S.V. Lichtenstein, A. Cheung, and J. Ye Transapical transcatheter aortic valve implantation in humans: initial clinical experience Circulation 114 2006 591 596
17. J. Ye, A. Cheung, and S.V. Lichtenstein Transapical transcatheter aortic valve implantation: 1-year outcome in 26 patients J Thorac Cardiovasc Surg 137 2009 167 173
18. H. Ruge, R. Lange, and S. Bleiziffer First successful aortic valve implantation with the CoreValve ReValving System via right subclavian artery access: a case report Heart Surg Forum 11 2008 E323 E324
19. C. Fraccaro, M. Napodano, and G. Tarantini Expanding the eligibility for transcatheter aortic valve implantation: the trans-subclavian retrograde approach using the III Generation CoreValve Revalving System J Am Coll Cardiol Interv 2 2009 828 833
20. H. Jilaihawi, T. Spyt, D. Chin, E. Logtens, J.C. Laborde, and J. Kovac Percutaneous aortic valve replacement in patients with challenging aortoiliofemoral access Catheter Cardiovasc Interv 72 2008 885 890
21. Medtronic's CoreValve shows subclavian access success in patients contraindicated for femoral approach [press release]. Available at: http://www.medicalnewstoday.com/articles/150929.php. Accessed July 23, 2009.
22. H. Jilaihawi, D. Chin, and M. Vasa-Nicotera Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis Am Heart J 157 2009 860 866